Somerset Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Hold
636
0.22% 84
2026
Q1
$585K Sell
636
-3
-0.5% -$3.04K 0.18% 94
2025
Q4
$687K Hold
639
0.21% 84
2025
Q3
$488K Hold
639
0.15% 111
2025
Q2
$498K Sell
639
-25
-4% -$19.4K 0.16% 103
2025
Q1
$548K Sell
664
-2
-0.3% -$1.66K 0.2% 81
2024
Q4
$514K Hold
666
0.19% 83
2024
Q3
$590K Sell
666
-4
-0.6% -$3.6K 0.22% 80
2024
Q2
$607K Buy
670
+97
+17% +$77.6K 0.25% 75
2024
Q1
$446K Sell
573
-4
-0.7% -$2.85K 0.18% 91
2023
Q4
$336K Sell
577
-25
-4% -$14.6K 0.15% 101
2023
Q3
$323K Hold
602
0.15% 106
2023
Q2
$282K Hold
602
0.12% 119
2023
Q1
$207K Hold
602
0.09% 142
2022
Q4
$220K Buy
+602
New +$213K 0.09% 138

Other funds holding LLY

Somerset Trust's LLY Position: Q2 2026 in Review

Somerset Trust held its Eli Lilly (LLY) position steady in Q2 2026 at 636 shares worth $763K. The position accounts for 0.22% of the portfolio, ranked #84.

Somerset Trust first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 968 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Somerset Trust held 636 shares of Eli Lilly worth $763K as of Q2 2026.
  • Somerset Trust left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.22% of Somerset Trust's portfolio in Q2 2026, its #84 holding.
  • Somerset Trust first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 968 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.